Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by PBaelishhon Feb 23, 2024 11:05am
87 Views
Post# 35895605

RE:RE:Press release

RE:RE:Press releasePS Ultimately with a 20t order in Q1, Gagnon thinks he can write-off how 2023 ended!!!

Think about it...
We have been begging for guidance with every quarterly release as he always waits until the last day possible to release results.  For example, Q4-23 was 2/3 over when he released results and, despite that, Gagnon offered no guidance on where 2023 would end up.

NOW, he releases unsolicited (VOLUME!) guidance, outside of a results release and, as has been noted, just ahead of the vote.

Only Gagnon and the bored have short memories.

Bottom line, FY2023 is far worse than we thought... and we will find out AFTER the vote, that he hopes will pass so they can enrich themselves at the expense of shareholders.

Insulting.
<< Previous
Bullboard Posts
Next >>